Article
Neuca Clinical Trials Inc, a holding company held by Neuca Group, the proprietor of Clinscience international CRO has joined forces with Florida-based oncological CRO, OncoBay Clinical.
The transaction gives NEUCA Group a 72.6% stake in OncoBay. Based in Tampa, Florida, the CRO was founded by Moffit Cancer Center.
Read more about the transaction here.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.